These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8085889)

  • 1. [Antibiotic pharmacokinetic indices and their significance in working out antibacterial therapy regimens and predicting their efficacy].
    Navashin SM; Navashin PS
    Antibiot Khimioter; 1993; 38(10-11):26-34. PubMed ID: 8085889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic therapy of angiogenic sepsis].
    Navashin Sm; Treskina OS
    Antibiot Khimioter; 1988 Jan; 33(1):67-71. PubMed ID: 3377596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and the dosage regimen of antimicrobial agents.
    Powers TE; Powers JD
    Ann Rech Vet; 1990; 21 Suppl 1():41S-45S. PubMed ID: 2080846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.
    Cazzola M; Matera MG; Noschese P
    Pulm Pharmacol Ther; 2000; 13(6):249-56. PubMed ID: 11061979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
    Schentag JJ
    J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial spectrum of an antibiotic and clinical categorization].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic factors of antibiotic efficacy.
    Rotschafer JC; Zabinski RA; Walker KJ
    Pharmacotherapy; 1992; 12(6 Pt 2):64S-70S. PubMed ID: 1480502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microbial resistance to antibiotics from the clinical viewpoint. Paradoxical therapy failures and the significance of pharmacokinetic-pharmacodynamic interactions in vivo].
    Rossi M; Gerber AU
    Ther Umsch; 2002 Jan; 59(1):11-9. PubMed ID: 11851041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future in vitro and animal studies: development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics.
    Nightingale CH
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):146S-149S. PubMed ID: 16305285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations.
    Liu P; Müller M; Derendorf H
    Int J Antimicrob Agents; 2002 Apr; 19(4):285-90. PubMed ID: 11978499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics.
    Kitamura Y; Yoshida K; Kusama M; Sugiyama Y
    Drug Metab Pharmacokinet; 2014; 29(6):455-62. PubMed ID: 25008846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
    Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S53-8. PubMed ID: 19000855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.
    Sy SK; Zhuang L; Derendorf H
    Expert Opin Drug Metab Toxicol; 2016; 12(1):93-114. PubMed ID: 26652832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
    Segreti J; Jones RN; Bertino JS
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage.
    Carbon C
    Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):510-6. PubMed ID: 2226482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.